To Compare the Frequency of Adverse Outcomes of Severe Versus Mild Oligohydramnios at Full Term
AbstractObjective: Oligohydramnios is a disorder that occurs in pregnancy and is characterized by an amniotic fluid deficiency. To determine the frequency of severe oligohydramnios in pregnant females at term presenting diagnosis of oligohydramnios and to compare the frequency of adverse outcomes of severe versus mild oligohydramnios at term.
MethodsThe Descriptive case series was held in Department of Obstetrics and Gynecology, CMH, Okara for 06 months i.e. from 28-12-2019 to 29-6-2020. Keeping in view the inclusion criteria, 100 pregnant females were enrolled. Then females underwent ultrasound and level of AFI was noted. If AFI<5cm, then severe oligohydramnios were labeled and females were divided in two groups i.e. mild oligohydramnios and severe oligohydramnios. Females were followed up till delivery and adverse outcomes were noted.
Results  The mean age group of females was 27.39±3.4 years. The severe oligohydramnios was found in 50 (50%) patients. When were compare the adverse outcome with oligohydramnios we found that the C-section [mild oligohydramnios =26 (52%) & in severe oligohydramnios =33(66%) females], perinatal death [mild oligohydramnios =3(6%) & in severe oligohydramnios=6(12%) females], lowApgar score in [mild oligohydramnios =26(52%) & in severe oligohydramnios=33(66%) females], similarly the low birth weight [mild oligohydramnios =1(2%) & in severe oligohydramnios=2(4%) females]. The adverse outcome showed statistically insignificant difference i.e. p-value>0.05.
Conclusion About half oligohydramnios patients had severe oligohydramnios, while there is no significant association of mild or severe oligohydramnios with adverse feto-maternal outcome.
Keywords:Oligohydramnios,Adverse Outcome, Mild, Severe, amniotic fluid index
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments firstname.lastname@example.org